An Open Platform urgently needed for
testing in Low- & Middle-Income Countries
Sample-to-result molecular diagnostic platforms and their suitability for infectious disease testing in low- and middle-income countries
Diagnostics are an essential, undervalued part of the health-care system. For many diseases, molecular diagnostics are the gold standard, but are not easy to implement in Low- and Middle-Income Countries (LMIC).
15th July 2024
